Novel device therapies in heart failure: focus on patient selection.

Although the trend toward reduced all-cause mortality was observed, the pooled analysis did not reach statistical significance, with a pooled HR of 0.92 (95% CI 0.73–1.16, p = 0.495).

also in 111,027 other papers